|
Re: aberaterone
|
3
|
Zenith Epigenetics
|
Jun 24, 2018 04:00PM
|
|
Re: what of zenith and all our shars we have from that origional invetment?
|
3
|
Resverlogix Corp.
|
Jun 24, 2018 06:24PM
|
|
Re: Odyssey Outcome
|
6
|
Resverlogix Corp.
|
Jun 25, 2018 10:58AM
|
|
Re: The last DSMB update of Feb 26th....
|
4
|
Resverlogix Corp.
|
Jun 25, 2018 11:07AM
|
|
Re: aberaterone
|
5
|
Zenith Epigenetics
|
Jun 25, 2018 12:12PM
|
|
Re: An invitation to join the conversation here on Agoracom
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jun 25, 2018 12:19PM
|
|
Re: Talking about an SSRA like its a slam dunk????
|
4
|
Resverlogix Corp.
|
Jun 25, 2018 02:38PM
|
|
Re: The last DSMB update of Feb 26th....
|
5
|
Resverlogix Corp.
|
Jun 25, 2018 02:45PM
|
|
Re: Intro
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jun 25, 2018 05:17PM
|
|
Re: Private message
|
1
|
Resverlogix Corp.
|
Jun 26, 2018 09:28AM
|
|
Re: The last DSMB update of Feb 26th....
|
3
|
Resverlogix Corp.
|
Jun 26, 2018 01:13PM
|
|
PFI-1 (aka PF-6405761)
|
5
|
Zenith Epigenetics
|
Jun 26, 2018 02:52PM
|
|
Re: The last DSMB update of Feb 26th....
|
6
|
Resverlogix Corp.
|
Jun 26, 2018 07:09PM
|
|
Re: Bioasis Announces Filing of Its Fourth Quarter and Fiscal Year-End Financial Statements and MD&A
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jun 26, 2018 09:23PM
|
|
Re: Bioasis Announces Filing of Its Fourth Quarter and Fiscal Year-End Financial Statements and MD&A
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jun 26, 2018 10:24PM
|
|
Re: The last DSMB update of Feb 26th....
|
2
|
Resverlogix Corp.
|
Jun 27, 2018 09:49AM
|
|
SAB and data
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jun 27, 2018 09:56AM
|
|
xB3-002: Glioblastoma
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jun 27, 2018 10:20AM
|
|
xB3-007 Neurodegeneration
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jun 27, 2018 10:27AM
|
|
Re: Managed to catch up with Mark Day last night...
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jun 27, 2018 01:04PM
|
